Three drugmakers settle with California over deals to keep generic medications off the market
by Samantha Masunaga, Los Angeles Times
Jul 30, 2019
3 minutes
Two pharmaceutical companies will pay the state of California a total of nearly $70 million to settle allegations that they violated antitrust laws by making agreements to delay generic drugs from entering the market, according to the California attorney general's office.
A third company will be subject to an injunction as part of the settlement.
Teva Pharmaceuticals Industries Ltd. illegally maintained a monopoly over sales of narcolepsy drug Provigil by entering "pay-for-delay" agreements
You’re reading a preview, subscribe to read more.
Start your free 30 days